SCHEMBL6595088

SCHEMBL6595088

COC(=O)c1scc(CCN)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.40
KMT2A Q03164 5/20 0.40
COMT P21964 1/20 0.36
F10 P00742 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
TAAR1 Q96RJ0 1/20 0.35
MAPT P10636 2/20 0.35
NPC1 O15118 1/20 0.35
CASP3 P42574 1/20 0.35
RAB9A P51151 1/20 0.35
SENP8 Q96LD8 1/20 0.35
SENP7 Q9BQF6 1/20 0.35
SENP6 Q9GZR1 1/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 3/20 0.35
MEN1 O00255 2/20 0.35
CYP3A4 P08684 2/20 0.35
POLB P06746 1/20 0.35
CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27472593 0.84 KMT2A (0.40) KDM4EKMT2AF10MAPTGAA
SCHEMBL6591889 0.82 KMT2A (0.39) KDM4EKMT2AF10MAPTCYP1A2
SCHEMBL6587977 0.82 KMT2A (0.39) KDM4EKMT2AF10MAPTGAA
SCHEMBL3306728 0.81 KMT2A (0.41) KDM4EKMT2AF10MAPTNPC1
SCHEMBL27595508 0.81 F10 (0.42) KDM4EKMT2AF10MAPTCYP1A2
SCHEMBL6593708 0.77 F10 (0.38) KDM4EKMT2AF10ALDH1A1HPGD
SCHEMBL6587446 0.77 CYP2A6 (0.37) KDM4EKMT2AF10ALDH1A1MAPT
SCHEMBL6593177 0.76 NQO2 (0.42) KDM4EKMT2AALDH1A1HPGDMAPT
SCHEMBL6594409 0.75 KDM4E (0.40) KDM4EKMT2AF10MAPTGAA
SCHEMBL4837886 0.75 F2 (0.39) KDM4EKMT2AF10MAPTCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1143855-C I (ortho)-anthranilamide derivatives as anti-coagulants ���ֹɷݹ�˾ 2004-03-31 CN disclosed
EP-1040108-B1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AG (DE) 2004-02-25 EP disclosed
US-6498185-B1 ENZYME FACTOR XA INHIBITORS BERLEX LABORATORIES, INC. 2002-12-24 US disclosed
US-6380221-B1 FOR THERAPY OF DISEASE-STATES CHARACTERIZED BY THROMBOTIC ACTIVITY BERLEX LABORATORIES, INC. 2002-04-30 US disclosed
CN-1282329-A I (ortho)-anthranilamide derivatives as anti-coagulants SCHERING AG (DE) 2001-01-31 CN disclosed
US-6140351-A FOR TREATING THROMBOSIS BERLEX LABORATORIES, INC. (US) 2000-10-31 US disclosed
EP-1040108-A1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 2000-10-04 EP disclosed
WO-1999032477-A1 ORTHO-ANTHRANILAMIDE DERIVATIVES AS ANTI-COAGULANTS SCHERING AKTIENGESELLSCHAFT (DE) 1999-07-01 WO disclosed